住院第一周内空腹血糖升高与合并糖尿病的 COVID-19 患者病情进展为重症相关：一项多中心观察性研究。
Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.
机构信息
Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China.
Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, China.
出版信息
J Diabetes. 2021 Jan;13(1):89-93. doi: 10.1111/1753-0407.13121. Epub 2020 Oct 30.
Abstract
Highlights Fasting blood glucose < 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19.
摘要
要点 建议在患有糖尿病的患者住院的第一周内将空腹血糖 < 10 mmol/L 作为血糖控制的目标。在 COVID-19 之前，HbA1c 水平较差可能与患有糖尿病的患者的严重程度无关。平均血糖似乎与 COVID-19 的不良预后无关。
相似文献
1
Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.住院第一周内空腹血糖升高与合并糖尿病的 COVID-19 患者病情进展为重症相关：一项多中心观察性研究。
J Diabetes. 2021 Jan;13(1):89-93. doi: 10.1111/1753-0407.13121. Epub 2020 Oct 30.
2
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
3
A Retrospective Study of 268 Patients with SARS-CoV-2 Infection to Evaluate the Association Between Blood Glucose and Severity of COVID-19 Pneumonia and Patient Mortality.一项回顾性研究纳入了 268 例 SARS-CoV-2 感染患者，旨在评估血糖与 COVID-19 肺炎严重程度和患者死亡率之间的关系。
Med Sci Monit. 2021 Aug 7;27:e932156. doi: 10.12659/MSM.932156.
4
[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].[新型冠状病毒肺炎治疗中应重视血糖管理]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 Mar;51(2):146-150. doi: 10.12182/20200360606.
5
J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes.空腹血糖水平与无糖尿病 COVID-19 患者严重程度之间的 J 型关联。
Diabetes Res Clin Pract. 2020 Oct;168:108381. doi: 10.1016/j.diabres.2020.108381. Epub 2020 Aug 25.
6
Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.入院时的空腹血糖是 COVID-19 患者 28 天死亡率的独立危险因素。
J Med Virol. 2021 Apr;93(4):2168-2176. doi: 10.1002/jmv.26608. Epub 2020 Nov 10.
7
Effect of fasting plasma glucose level in severe fever and thrombocytopenia syndrome patients without diabetes.重症发热伴血小板减少综合征患者无糖尿病时的空腹血糖水平的影响。
PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0012125. doi: 10.1371/journal.pntd.0012125. eCollection 2024 Apr.
8
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters.空腹血糖与新冠病毒疾病严重程度：非线性关系至关重要。
Diabetes Care. 2020 Dec;43(12):3113-3116. doi: 10.2337/dc20-1941. Epub 2020 Oct 13.
9
Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients.新型冠状病毒肺炎后综合征患者的血糖升高/糖尿病、血浆致动脉粥样硬化指数与肥胖的相关性。
Endocrine. 2024 May;84(2):470-480. doi: 10.1007/s12020-023-03611-4. Epub 2023 Nov 25.
10
No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection.没有证据表明感染 SARS-CoV-2 后会长期破坏糖代谢控制。
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1009-e1019. doi: 10.1210/clinem/dgab792.
引用本文的文献
1
The clinical features and outcomes of diabetes patients infected with COVID-19: a systematic review and meta-analysis comprising 192,693 patients.2019冠状病毒病感染糖尿病患者的临床特征与转归：一项纳入192,693例患者的系统评价与Meta分析
Front Med (Lausanne). 2025 Jan 29;12:1523139. doi: 10.3389/fmed.2025.1523139. eCollection 2025.
2
Association Between COVID-19 and Diabetes Management Indices in Japanese Type 2 Diabetes Mellitus Patients: A Single-Center, Retrospective Study.日本2型糖尿病患者中COVID-19与糖尿病管理指标之间的关联：一项单中心回顾性研究
Infect Drug Resist. 2024 Aug 29;17:3759-3767. doi: 10.2147/IDR.S475917. eCollection 2024.
3
Glycated albumin in the detection of diabetes during COVID-19 hospitalization.糖化白蛋白在 COVID-19 住院期间检测糖尿病中的应用。
PLoS One. 2024 Mar 18;19(3):e0297952. doi: 10.1371/journal.pone.0297952. eCollection 2024.
4
The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course-A Narrative Review.糖尿病和高血糖对新型冠状病毒肺炎感染病程的影响——一篇叙述性综述
Front Clin Diabetes Healthc. 2022 Mar 10;3:812134. doi: 10.3389/fcdhc.2022.812134. eCollection 2022.
5
COVID-19 Induces Body Composition and Metabolic Alterations.新冠病毒引发身体成分和代谢改变。
Cureus. 2023 Jan 25;15(1):e34196. doi: 10.7759/cureus.34196. eCollection 2023 Jan.
6
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.中东人群中 COVID-19 的预后：已知与未知
Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022.
7
Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes.糖化白蛋白和糖化白蛋白/糖化血红蛋白可预测韩国2型糖尿病患者2019冠状病毒病从轻症向重症的进展。
J Clin Med. 2022 Apr 21;11(9):2327. doi: 10.3390/jcm11092327.
8
A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort.来自土耳其队列的 COVID-19 时间事件数据的风险因素综合排名。
Comput Biol Chem. 2022 Jun;98:107681. doi: 10.1016/j.compbiolchem.2022.107681. Epub 2022 Apr 9.
9
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin.糖尿病、二甲双胍与新冠病毒病的临床病程：二甲双胍的治疗效果、作用机制及应用建议
Front Pharmacol. 2022 Mar 9;13:784459. doi: 10.3389/fphar.2022.784459. eCollection 2022.
10
Factors Affecting the Incidence, Progression, and Severity of COVID-19 in Type 1 Diabetes Mellitus.影响 1 型糖尿病 COVID-19 发病率、进展和严重程度的因素。
Biomed Res Int. 2021 Nov 23;2021:1676914. doi: 10.1155/2021/1676914. eCollection 2021.
本文引用的文献
1
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
2
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19.在糖尿病、糖尿病前期和肥胖症患者中，葡萄糖代谢受损与严重的 COVID-19 相关。
J Med Virol. 2021 Jan;93(1):409-415. doi: 10.1002/jmv.26227. Epub 2020 Jul 17.
3
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.COVID-19 合并糖尿病住院患者的表型特征和预后：CORONADO 研究。
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
4
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?COVID-19 影响下的高血糖患者结局：我们能否在血糖控制方面做得更好？
Diabetes Care. 2020 Jul;43(7):1408-1415. doi: 10.2337/dc20-0723. Epub 2020 May 19.
5
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.糖化血红蛋白与 COVID-19 患者的全身炎症、高凝状态和预后有关。
Diabetes Res Clin Pract. 2020 Jun;164:108214. doi: 10.1016/j.diabres.2020.108214. Epub 2020 May 18.
6
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
7
Endocrine and metabolic link to coronavirus infection.内分泌和代谢与冠状病毒感染的关联。
Nat Rev Endocrinol. 2020 Jun;16(6):297-298. doi: 10.1038/s41574-020-0353-9.
8
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病（COVID-19）进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
Zotero 插件